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Vascular networks were created with endothelial colony-forming cells de-
rived from cord blood.
Results: MSCs from various tissue sources demonstrated appropriate
stem cell markers via flow cytometry. P-MSCs exhibited increased apoptosis
in response to H2O2 compared with ASCs and BM-MSCs (P .001). ASCs
demonstrated increased apoptosis after exposure to TNF- and hypoxia
compared with MSCs (P  .001). No difference in senescence activity was
detected by various MSCs. ASCs demonstrated elevated overall survival in
response to H2O2 (P  .05). BM-MSCs and P-MSCs exhibited increased
survival after exposure to TNF- and hypoxia (P .001). ASCs exhibited no
difference in tube formation after exposure to H2O2 compared with con-
trols. However, ASCs exhibited significant decreases in mean tube length
after exposure to TNF- and hypoxic conditions compared with controls
(P  .05).
Conclusions: ASCs remain potent under oxidative stress conditions,
whereas P-MSCs and BM-MSCs thrive under inflammatory and hypoxic
conditions. This report outlines how MSCs respond to various conditions
unique to vascular injury and indicate that ASCs may be the optimal cell
source in critical limb ischemia, because oxidative stress is the dominant
factor determining cell viability in this condition.
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Objectives: The utility of after-hours duplex venous scanning (DVS)
for suspected DVT in emergency department (ED) patients has been de-
bated. Availability of safe, prophylactic, low-molecular-weight heparin, cost
containment efforts, and retention of scarce sonographers have to be bal-
anced against 24/7 demand for services. We determined the incidence of
DVT in DVS ordered after hours, correlation between the Wells score and
prophylactic anticoagulation, as well as urgently performed DVS, and com-
plications of delaying DVS until regular hours.
Methods: Records of all ED encounters between July 1, 2009 and
June 30, 2010 associated with a DVS ordered after hours were reviewed.
The decisions to prophylactically anticoagulate andwhether to performDVS
urgently or delayed until regular hours were at the discretion of the ED
physician and a vascular surgeon. DVS findings, number of urgent and
delayed studies, the Wells scores, D-dimer levels, and outcomes were re-
corded.
Results: DVT was found in 12% (n  22) of 181 DVS ordered after
hours. DVT was found in 19% of 42 DVS done urgently and in 10% of 139
DVS delayed an average 10 hours 17 minutes (P  NS). Wells scores were
available for all patients and D-dimer levels for 43 (Table). Seventy-eight
percent of patients with a Wells score 3 had prophylactic anticoagulation,
whereas only 40% of patients with a Wells score 3 had prophylactic
anticoagulation (P .0001). In contrast, 36% of patients with a Wells score
 3 had urgent DVS and 20% of patients with a Wells’ score3 had urgent
DVS (p  ns). Prophylactic anticoagulation was given to 86% of patients
eventually found to have DVT versus 40% of patients eventually found to
have no DVT (P  .0001). There were no PEs or bleeding complications.
Conclusions: The incidence of DVT in ED patients who had urgent
after hours DVS was no different than in those whose DVS was delayed until
regular hours. High pretest probability can be achieved with clinical evalu-
ation prior to DVS, and this guided the decision to prophylactically antico-
agulate but did not impact the decision to perform urgent DVS. Most
patients eventually found to have DVT did receive prophylactic anticoagu-
lation, and delay of DVS did not result in complications. We believe that
most patients in whom there is high clinical suspicion for DVT can safely get
prophylactic anticoagulation and delayed DVS. Patients in whom there is
low clinical suspicion should not get urgent DVS.
Table. Wells score and D-dimer results
Variable Wells score  3 (%) D-dimer (%)
Sensitivity 64 100
Specificity 88 17
Positive predictive value 42 9
Negative predictive value 95 100
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Objectives: This study evaluated the safety of an observation protocol
in asymptomatic patients with moderate internal carotid artery stenosis, and
to identify characteristics associated with disease progression.
Methods: Patients with asymptomatic moderate internal carotid dis-
ease (peak systolic velocity [PSV]  125 cm/s and end diastolic velocity
[EDV] 125 cm/s by duplex ultrasound imaging) correlating to 50% to
75% diameter reduction were monitored for 3 years. Progression to greater
than 75% diameter reduction (EDV 125 cm/s) or presentation with focal
neurologic symptoms (stroke, amaurosis fugax, transient ischemic attack)
was documented. Comorbidities, smoking status, and medications were
recorded. Log-rank testing, Wilcoxon models, and Kaplan-Meier plots
provided statistical analysis.
Results: During follow up, 26 of 288 patients (9%; 137 men, 151
women) developed symptoms (stroke: 9 [3.1%]; transient ischemic attack: 3
[1%]; amaurosis fugax: 3 [1%]), or asymptomatic increase in diameter to
75% (11 patients [3.8%]). All-cause mortality was 11% (33 patients).
Seventeen patients (5.9%) underwent carotid endarterectomy and five
(1.7%) had carotid stent placement. The event incidence was significantly
higher for men (P .02), but survival was not different. The rate of disease
progression or development of symptoms was 5.5% at 12 months and
increased to 7.2% by 24 months. Comorbidities with the highest associated
event incidences were coronary artery disease (8.1%), hyperlipidemia (7.3%),
and hypertension (6.7%). Medications associated with lower event inci-
dences were insulin (2.8%) and angiotensin-receptor blockers (1.9%).
Conclusions: Sequential surveillance of asymptomatic patients with
moderate carotid disease is safe, with only 5% becoming symptomatic and 4%
having disease progression. Male patients with coronary artery disease,
hyperlipidemia, and hypertension are at increased risk and are candidates for
frequent screening and/or early intervention.
Deep Venous Thrombosis After Saphenous Endovenous Radiofre-
quency Ablation: Is It Predictable?
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Objectives: Endovenous radiofrequency ablation (RFA) is a safe and
effective treatment for varicose veins secondary to saphenous reflux. Deep
venous thrombosis (DVT) is a known complication of this procedure. The
purpose of this study is to describe the frequency of DVT after RFA and
associated predisposing factors.
Methods: We performed a retrospective data analysis from December
2008 to December 2011, during which 277 consecutive office-based RFA
were performed in our institution using the VNUS ClosureFast catheter.
Duplex scans were completed 2 weeks postprocedure in all patients to
confirm saphenous vein obliteration and evaluate the deep venous system for
thrombosis. Risk factors assessed for development of DVT included greater
vs lesser saphenous, side treated, number of cycles used, hypercoagulable
state, history of DVT, tobacco use, medications (oral contraceptives, aspirin,
warfarin, clopidogrel), and vein diameter at the junction of the superficial
and deep systems.
Results: Seventy percent of the patients were female, 56% were right
side, and 86% were performed on the greater saphenous vein. Mean age was
54  14 (range, 23-88 years). 3% of patients had a diagnosis of hypercoag-
ulable state and 8% had a history of DVT. Follow-up ultrasound imaging
showed thrombus protrusion into the deep system without occlusion was
present in 11 patients (4%). DVT, as defined by thrombus protrusion with
complete occlusion of the femoral or popliteal vein, developed in two
patients (0.7%). PreviousDVTwas the only factor associated withDVT (P
.018). Although not statistically significant, there was a trend toward higher
risk of DVT in LSV patients. Factors associated with protrusion into the
deep system were lesser saphenous vein (P  .035), and factor V Leiden
(P  .026).
Conclusions: The use of RFA to treat patients with saphenous reflux
involves a small but definite risk of DVT. This study demonstrates that the
risk of DVT or any thrombus protrusion in to the deep system is greater in
patients with previous DVT, factor V Leiden, and treatment of the lesser
saphenous vein. Periprocedural anticoagulation should be considered in this
subset to reduce the risk of complication after RFA.
Response of Neointimal Hyperplasia and the Adventitial Sca1 Stem
Cell to Nitric Oxide
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Objectives:Recently, Sca1 stem cells have been identified to reside in
the adventitia of the arterial wall. However, their role in the formation of
neointimal hyperplasia is unknown, as is the effect of nitric oxide (NO) on
these cells. We hypothesize that Sca1 stem cells contribute to neointimal
development and that NO limits the involvement of adventitial Sca1 cells
in the arterial injury response, thereby inhibiting neointimal hyperplasia.
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